Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2016 - 2025)

Prestige Consumer Healthcare has reported Other Non-Current Assets over the past 15 years, most recently at $3.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 40.16% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $3.8 million, down 40.16%, while the annual FY2025 figure was $3.3 million, 42.83% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $3.8 million at Prestige Consumer Healthcare, up from $3.4 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $6.7 million in Q3 2024 and troughed at $2.5 million in Q2 2021.
  • A 5-year average of $3.9 million and a median of $3.3 million in 2022 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: surged 99.84% in 2023 and later tumbled 51.48% in 2025.
  • Year by year, Other Non-Current Assets stood at $2.9 million in 2021, then grew by 9.13% to $3.2 million in 2022, then surged by 99.84% to $6.3 million in 2023, then rose by 0.57% to $6.3 million in 2024, then crashed by 40.16% to $3.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for PBH at $3.8 million in Q4 2025, $3.4 million in Q3 2025, and $3.0 million in Q2 2025.